Resveratrol suppresses insulin-like growth factor I-induced osteoblast migration: attenuation of the p44/p42 MAP kinase pathway

References

• Rauf A, Imran M, Suleria HAR, et al. A comprehensive review of the health perspectives of resveratrol. Food Funct. 2017;8(12):4284–4305.
   Web of Science ®Google Scholar
• Yap S, Qin C, Woodman OL. Effects of resveratrol and flavonols on cardiovascular function: physiological mechanisms. Biofactors. 2010;36(5):350–359.
   PubMed Web of Science ®Google Scholar
• Sawda C, Moussa C, Turner RS. Resveratrol for Alzheimer’s disease. Ann N Y Acad Sci. 2017;1403(1):142–149.
   PubMed Web of Science ®Google Scholar
• Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339(8808):1523–1526.
   Web of Science ®Google Scholar
• Biagi M, Bertelli AA. Wine, alcohol and pills: what future for the French paradox? Life Sci. 2015;131:19–22.
   PubMed Web of Science ®Google Scholar
• Kubo JT, Stefanick ML, Robbins J, et al. Preference for wine is associated with lower hip fracture incidence in post menopausal women. BMC Womens Health. 2013;13(1):36.
   PubMedGoogle Scholar
• Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002;2(4):389–406.
   PubMed Web of Science ®Google Scholar
• Sims NA, Gooi JH. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol. 2008;19(5):444–451.
   PubMed Web of Science ®Google Scholar
• Clements TL, Chernausek SD. Genetic strategies for elucidating insulin-like growth factor action in bone. Growth Horm IGF Res. 2004;14(3):195–199.
   PubMed Web of Science ®Google Scholar
• Niu T, Rosen CJ. The insulin-like growth factor-1 gene and osteoporosis: A critical appraisal. Gene. 2005;361:38–56.
   PubMed Web of Science ®Google Scholar
• Lombardi G, Tauchmanova L, Di Somma C, et al. Somatopause: dismetabolic and bone effects. J Endocrinol Invest. 2005;28(10 Suppl):36–42.
   PubMedGoogle Scholar
• Garnero P, Sornay-Rendu E, Delmas PD. Low serum IGF-1 and occurrence of 3 osteoporotic fractures in postmenopausal women. Lancet. 2000;355(9207):898–899.
   PubMed Web of Science ®Google Scholar
• Noda T, Tokuda H, Yoshida M, et al. Possible involvement of phosphatidylinositol 3-kinase/Akt pathway in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblasts. Horm Metab Res. 2005;37(5):270–274.
   PubMed Web of Science ®Google Scholar
• Hanai Y, Tokuda H, Ishisaki A, et al. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I- induced alkaline phosphatase activity in osteoblast-like MC3T3-E1 cells. Mol Cell Endocrinol. 2006;251(1–2):42–48.
   PubMed Web of Science ®Google Scholar
• Su P, Tian Y, Yang C, et al. Mesenchymal stem cell 13 migration during bone formation and bone diseases therapy. Int J Mol Sci. 2018;19(8):E2343. 14
   PubMed Web of Science ®Google Scholar
• Kawabata T, Tokuda H, Sakai G, et al. Repression of IGF-I-induced osteoblast migration by (-)17 epigallocatechin gallate through p44/p42 MAP kinase signaling. Biomed Rep. 2018;9(4):318–326.
   PubMed Web of Science ®Google Scholar
• Mizutani K, Ikeda K, Kawai Y, et al. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3 E1 cells. Biochem Biophys Res Commun. 1998;253(3):859–863.
   PubMed Web of Science ®Google Scholar
• Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191–196.
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high calorie diet. Nature. 2006;444(7117):337–342.
   PubMed Web of Science ®Google Scholar
• Kawabata T, Tokuda H, Fujita K, et al. Resveratrol inhibits the epidermal growth factor-induced migration of osteoblasts: the suppression of SAPK/JNK and Akt. Cell Physiol Biochem. 2017;43(3):1025–1036.
   PubMedGoogle Scholar
• Sudo H, Kodama HA, Amagai Y, et al. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983;96(1):191–198.
   PubMed Web of Science ®Google Scholar
• Kozawa O, Suzuki A, Tokuda H, et al. Prostaglandin F2α stimulates interleukin-6 synthesis via activation of PKC in osteoblast-like cells. Am J Physiol. 1997;272(2 Pt 1):E208–E211.
   PubMedGoogle Scholar
• Karagiosis SA, Chrisler WB, Bollinger N, et al. Lysophosphatidic acid-induced ERK activation and chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF receptor transactivation. J Cell Physiol. 2009;219(3):716–723.
   PubMed Web of Science ®Google Scholar
• Kawabata T, Tokuda H, Sakai G, et al. HSP70 inhibitor suppresses IGF-I-stimulated migration of osteoblasts through p44/p42 MAP Kinase. Biomedicines. 2018;6(4):109.
   Web of Science ®Google Scholar
• Laemmli UK; Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–685.
   Web of Science ®Google Scholar
• Kato K, Ito H, Hasegawa K, et al. Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 rat glioma cells. J Neurochem. 1996;66(3):946–950.
   PubMed Web of Science ®Google Scholar
• Kuroyanagi G, Tokuda H, Matsushima-Nishiwaki R, et al. Resveratrol suppresses prostaglandin F2α-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. Arch Biochem Biophys. 2014;542:39–45.
   PubMed Web of Science ®Google Scholar
• Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007;450(7170):712–716.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zeng SX, Zhang Y, et al. A small molecule inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53. EMBO Mol Med. 2012;4(4):298‑312.
   Web of Science ®Google Scholar
• Alessi DR, Cuenda A, Cohen P, et al. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270(46):27489–27494.
   PubMed Web of Science ®Google Scholar
• Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone: biology and clinical applications. J Bone Joint Surg Am. 2002;84(6):1032–1044.
   PubMed Web of Science ®Google Scholar
• Reddi AH, Roodman D, Freeman C, et al. Mechanisms of tumor metastasis to the bone: challenges and opportunities. J Bone Miner Res. 2003;18(2):190–194.
   PubMed Web of Science ®Google Scholar
• Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol. 2011;6(1):121–145.
   PubMedGoogle Scholar